Orgenesis Inc. announced the appointment of Sav DiPasquale as President and Chief Executive Officer. Mr. DiPasquale succeeds Jacob BenArie, who has been appointed Chief Executive Officer of the company's private subsidiary, Orgenesis Ltd. Prior to joining Orgenesis, Mr. DiPasquale worked with GlaxoSmithKline Inc. There, DiPasquale served in various technology and marketing capacities including his most recent role as Vice President, Business Development and Corporate Planning.